Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Bush

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Pharmacology|March 1, 1989
Novel adrenergic compounds. I. Receptor interactions of ABBOTT-54741 [(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthtyl)imidazoline], an alpha-adrenergic agonistJ J Kyncl, J F DeBernardis, E N Bush, et al.
Journal of Medicinal Chemistry|October 1, 1989
Active reduced-size hexapeptide analogues of luteinizing hormone-releasing hormoneF Haviv, C A Palabrica, E N Bush, et al.
Journal of Medicinal Chemistry|September 1, 1989
LH-RH antagonists: design and synthesis of a novel series of peptidomimeticsB De, J J Plattner, E N Bush, et al.
Journal of Cardiovascular Pharmacology|November 1, 1985
Adrenergic and dopaminergic properties of dopamine sulfoconjugatesJ J Kyncl, S A Buckner, H Brondyk, et al.
Biochemical and Biophysical Research Communications|April 14, 1987
Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypesG P Budzik, S L Firestone, E N Bush, et al.
Journal of Medicinal Chemistry|October 1, 1985
Conformationally defined adrenergic agents. 1. Design and synthesis of novel alpha 2 selective adrenergic agents: electrostatic repulsion based conformational prototypesJ F DeBernardis, D J Kerkman, M Winn, et al.
Journal of Medicinal Chemistry|March 4, 1994
In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormoneF Haviv, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry|October 16, 1992
Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokineticsF Haviy, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry|February 5, 1993
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonistsF Haviv, T D Fitzpatrick, R E Swenson, et al.
Journal of Medicinal Chemistry|April 2, 1993
The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonistsF Haviv, T D Fitzpatrick, C J Nichols, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|March 1, 1989
Novel adrenergic compounds. I. Receptor interactions of ABBOTT-54741 [(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthtyl)imidazoline], an alpha-adrenergic agonistJ J Kyncl, J F DeBernardis, E N Bush, et al.
Journal of Medicinal Chemistry|October 1, 1989
Active reduced-size hexapeptide analogues of luteinizing hormone-releasing hormoneF Haviv, C A Palabrica, E N Bush, et al.
Journal of Medicinal Chemistry|September 1, 1989
LH-RH antagonists: design and synthesis of a novel series of peptidomimeticsB De, J J Plattner, E N Bush, et al.
Journal of Cardiovascular Pharmacology|November 1, 1985
Adrenergic and dopaminergic properties of dopamine sulfoconjugatesJ J Kyncl, S A Buckner, H Brondyk, et al.
Biochemical and Biophysical Research Communications|April 14, 1987
Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypesG P Budzik, S L Firestone, E N Bush, et al.
Journal of Medicinal Chemistry|October 1, 1985
Conformationally defined adrenergic agents. 1. Design and synthesis of novel alpha 2 selective adrenergic agents: electrostatic repulsion based conformational prototypesJ F DeBernardis, D J Kerkman, M Winn, et al.
Journal of Medicinal Chemistry|March 4, 1994
In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormoneF Haviv, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry|October 16, 1992
Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokineticsF Haviy, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry|February 5, 1993
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonistsF Haviv, T D Fitzpatrick, R E Swenson, et al.
Journal of Medicinal Chemistry|April 2, 1993
The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonistsF Haviv, T D Fitzpatrick, C J Nichols, et al.
Pageof 3